JPM 2026: Pharma, Biotech, and Industry Trends Unveiled
TL;DR Summary
The upcoming JPMorgan Healthcare Conference will showcase industry updates on drug pipelines, M&A activity, and the impact of recent drug pricing deals, with a focus on managing patent expirations, obesity treatments, and potential new drug developments from major pharma companies like Bristol Myers Squibb, Merck, Novo Nordisk, and Eli Lilly.
Topics:business#drug-pricing#healthcare#jpmorgan-healthcare-conference#obesity-drugs#patent-cliff#pharmaceutical-industry
- Healthy Returns: What to expect from pharma at the JPM conference CNBC
- JPM to bring more deals and happy CEOs statnews.com
- At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun BioSpace
- JPM 2026: What to know about the San Francisco conference Modern Healthcare News
- Will biotech's big JPM conference signal a new normal for the industry and San Francisco? The Business Journals
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 4 min read
Condensed
93%
689 → 50 words
Want the full story? Read the original article
Read on CNBC